Worst performer was WHR:Warehouse REIT dropping 14% after lackluster results. They are 20% down now, but fundamentals are strong and the dividend is good, so I'll keep hold of them. I've abandoned my 15% drop equals sell rule for magic formula shares as I would have sold virtually all of them given the state of the current market, and I won't take all those paper losses as I'd just replace them with something that's likely to do the same.
OPTI:Optibiotix dropped 9% in some of my holdings. If there's no news
soon we're going to sink like a brick.
EDV:Endeavour Mining also dropped 9%, which is unusual for this
normally popular share.
SBTX:SkinBioTherapeutics has also been a disaster and dropped another
5% this week to go 66% down. All my microbiome investments are utterly
rubbish. So much for it being the future!
Share of the Week is JLP:Jubilee Metals, which climbed 12%, 16% and 26%
depending on the holding, and one of them is in profit!
Here's the ISA and shares portfolio after week 45 of year 8.
| Weekly Change | |||
| Cash | £218.04 | -£13.64 | |
| Portfolio cost | £87,354.57 | +£509.89 | |
|
Portfolio sell value (bid price-commission) |
£22,257.57 | (-74.5%) | -£858.62 |
| Potential profits | £92.77 | +£92.77 | |
| Yr 8 Dividends | £96.83 | +£0 | |
| Yr 8 Interest | £1.40 | +£0 | |
| Yr 8 Profit from sales | -£10,795.53 | +£0 | |
| Yr 8 proj avg monthly profit | -£1,034.35 | (-21.0%) | +£21.96 |
| Total Dividends | £11,865.75 | +£0 | |
| Total Interest | £1.40 | +£0 | |
| Total Profit from sales | £17,298.53 | +£0 | |
| Average monthly cash profit | £305.08 | (6.2%) | -£0.92 |
|
(Sold stocks profit + Dividends - Fees / Months) |
|||
| Compound performance | 49% | +0% |
I won £375 on the premium bonds and Nationwide are dishing out £100 dividend, so I added £500 to my ISA and bought 7,002 shares in JLP:Jubilee Metals at 7.14p costing £509.89. Very happy to say that they promptly rose to 8.5p, and so with my other AJ Bell ISA holding bought at 8.05p they are now up by 9% making £92 potential profit. Hopefully the news flow will continue and we can get back to the 15p range this should be at.
Not much else happened other than dropping £858 in value.
Very depressing chart
Quite remarkable how keen we are to follow the trend line
Very depressing chart
Quite remarkable how keen we are to follow the trend line
The SIPP looks like this after week 393 overall and week 29 of year 8.
| Weekly Change | ||||
| Cash | £544.51 | -£9.89 | ||
| Portfolio cost | £94,615.50 | +£0 | ||
|
Portfolio sell value (bid price - commission) |
£27,977.62 | (-70.4%) | -£797.17 | |
| Potential profits | £547.96 | +£8.81 | ||
| Yr 8 Dividends | £180.94 | +£0 | ||
| Yr 8 Interest | £2.15 | +£0 | ||
| Yr 8 Profit from sales | -£9,820.16 | +£0 | ||
| Yr 8 proj avg monthly profit | -£1,451.67 | (-26.9%) | +£50.32 | |
| Total Dividends | £14,323.72 | +£0 | ||
| Total Interest | £2.40 | +£0 | ||
| Total Profit from sales | £10,613.59 | +£0 | ||
| Average monthly cash profit | £263.15 | (4.9%) | -£0.78 | |
|
(Sold stocks profit + Dividends - Fees / Months) |
||||
| Compound performance | 37% | +0% |
Very little happened other than paying monthly fees and watching the value drop by £797. Potential profits went up by a massive £8 thanks to a 4% rise in CAML:Central Asia Metals countering the losses elsewhere.
Pretty much the same as the ISA
The trading account looks like this after week 359 overall and week 47 of year 7.
| Weekly Change | |||
| Cash | £20.26 | +£0 | |
| Portfolio cost | £1,763.50 | +£0 |
|
|
Portfolio sell value (bid price - commission) |
£954.11 | (-45.9%) | +£76.69 |
| Potential profits | £0 | +£0 | |
| Year 7 Dividends | £0.00 | +£0 | |
| Year 7 Interests | £0.03 | +£0 | |
| Year 7 Profit | -£1,157.99 | +£0 | |
| Yr 7 proj avg monthly profit | -£106.70 | (-72.6%) | +£2.32 |
| Dividends | £60.10 | +£0 | |
| Interest | £0.03 | +£0 | |
| Profit from sales | -£930.69 | +£0 | |
| Average monthly cash profit | -£10.51 | (-7.2%) | +£0.03 |
|
(Sold stocks profit + Dividends - Fees / Months) |
Five weeks left to go in Year 7 and JLP:Jubilee Metals may be staging a rally. It can't rise enough to remove the £1,157 loss suffered when DDDD:4D Pharma went bust, but if I get a chance to sell then it could make it look a little less desperate. Certainly the £76 rise in value was very welcome, despite OPTI:Optibiotix trying to remove it.
A rare tick up.
Not enough to get back above the trend line.
We're expecting PBX:Probiotix results any day now. If they are anything short of spectacular then I'm very worried for the future of my microbiome investments. We've been assured over and over that things are going well for them, so anything short of a decent profit will be a disaster for the PBX and OPTI share prices. I'm almost dreading the RNS, but at least we'll be put out of our misery when it finally lands.
